Bamlanivimab (BAM) is an early-intervention treatment for those who have tested positive and have been diagnosed with COVID-19 within the past three days. Under an FDA Emergency Use Order, the treatment may significantly reduce the chance of worsening symptoms and hospitalization due to complications of COVID-19.
